Turbocharge the Development of the Best-In-Class Kinase Inhibitor Products, to Enhance Specificity, Overcome Resistance to Deliver Safe & Durable Clinical Responses Celebrating 20 years of FDA ...

Australia's CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial year which ...

Skye Petroleum, Inc. provides production chemical treatment services to oil companies in the United States. It offers production chemicals, which include solvents, dispersants, and wax inhibitors; ...